CASE REPORT: Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta -globin gene deletion

A young woman originally from Cape Verde islands presented with mild sickle cell disease. Her blood counts and hemoglobin analysis results initially suggested that she might be either homozygous for the sickle cell hemoglobin (Hb S) with concomitant alpha -thalassemia, or compound heterozygous for H...

Full description

Saved in:
Bibliographic Details
Published in:European journal of haematology Vol. 78; no. 1; pp. 82 - 85
Main Authors: Andersson, BAnders R, Wering, Mikaela EL, Luo, Hong-Yuan, Basran, Raveen K, Steinberg, Martin H, Smith, Hedy P, Chui, David HK
Format: Journal Article
Language:English
Published: 01-01-2007
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A young woman originally from Cape Verde islands presented with mild sickle cell disease. Her blood counts and hemoglobin analysis results initially suggested that she might be either homozygous for the sickle cell hemoglobin (Hb S) with concomitant alpha -thalassemia, or compound heterozygous for Hb S and beta super(0)-thalassemia, deletional delta beta -thalassemia or hereditary persistence of fetal hemoglobin (HPFH). We utilized a novel polymerase chain reaction (PCR)-based screening technique and found a hitherto unrecognized 7.7-kb deletion, starting from the HBB IVSII to 3' downstream of the beta -globin gene. This diagnostic approach can be applied to decipher other similar deletional mutations. This is the second known deletion that removes the 3'-end but preserves the integrity of the 5'-end of the beta -globin gene. Furthermore, the identification of the deletion allows proper genetic counseling for affected families.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-2
ISSN:0902-4441
1600-0609
DOI:10.1111/j.1600-0609.2006.00771.x